Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad-HGF in Ischemic Heart Disease
NCT01925352Phase 2Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Nov 2012
- Primary completion
- Dec 2015
- Modality
- Gene Editing, Gene Silencing, Viral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of adenovirus-hepatocyte growth factor in ischemic heart disease (IHD), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
adenovirus-hepatocyte growth factor
03
Conditions
ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT01925352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01925352.